Bristol-Myers Squibb Company Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 8 | -$4.41 | -$4.41 | -$4.41 |
| Q2 2024 | 5 | $1.62 | $1.62 | $1.62 |
| Q3 2024 | 13 | $1.51 | $1.67 | $1.58 |
| Q4 2024 | 7 | $1.50 | $1.50 | $1.50 |
| Q1 2025 | 8 | $1.86 | $1.86 | $1.86 |
| Q2 2025 | 9 | $1.97 | $1.97 | $1.97 |
| Q3 2025 | 10 | $1.77 | $1.77 | $1.77 |
| Q4 2025 | 11 | $1.82 | $1.82 | $1.82 |
| Q1 2026 | 10 | $1.60 | $1.60 | $1.60 |
| Q2 2026 | 11 | $1.85 | $1.85 | $1.85 |
| Q3 2026 | 5 | $1.87 | $1.87 | $1.87 |
| Q4 2026 | 5 | $1.85 | $1.85 | $1.85 |
Bristol-Myers Squibb Company Earnings Date And Information
Bristol-Myers Squibb Company last posted its earnings results on Friday, July 26th, 2024. The company reported $2.07 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.45. The company had revenue of 12.20 B for the quarter and had revenue of 45.01 B for the year. Bristol-Myers Squibb Company has generated $4 earnings per share over the last year ($3.86 diluted earnings per share) and currently has a price-to-earnings ratio of -16.26. Bristol-Myers Squibb Company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 31st, 2024 based on prior year's report dates.
Bristol-Myers Squibb Company Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/26/2024 | Q2 2024 | $1.62 | $0.83 | -0.79 | $11.54 B | $12.20 B |
| 04/25/2024 | Q1 2024 | -$4.41 | -$5.89 | -1.48 | $11.87 B | |
| 02/13/2024 | Q4 2023 | $0.87 | $11.48 B | |||
| 10/26/2023 | Q3 2023 | $1.76 | $0.94 | -0.82 | $10.96 B | $10.97 B |
| 07/27/2023 | Q2 2023 | $1.99 | $0.99 | -1 | $11.77 B | $11.23 B |
| 04/27/2023 | Q1 2023 | $1.98 | $1.08 | -0.9 | $11.34 B | |
| 02/14/2023 | Q4 2022 | $0.96 | $11.41 B | |||
| 10/26/2022 | Q3 2022 | $0.75 | $11.14 B | $11.22 B | ||
| 07/27/2022 | Q2 2022 | $1.79 | $0.67 | -1.12 | $11.89 B | |
| 04/29/2022 | Q1 2022 | $1.92 | $0.60 | -1.32 | $11.65 B | |
| 02/09/2022 | Q4 2021 | $1.10 | $12.04 B | $11.99 B | ||
| 10/27/2021 | Q3 2021 | $1.91 | $0.70 | -1.21 | $11.61 B | $11.62 B |
| 07/28/2021 | Q2 2021 | $1.88 | $0.47 | -1.41 | $11.27 B | $11.70 B |
| 04/29/2021 | Q1 2021 | $1.80 | $0.90 | -0.9 | $11.07 B | |
| 02/10/2021 | Q4 2020 | -$4.45 | $10.73 B | $11.07 B | ||
| 11/05/2020 | Q3 2020 | $1.49 | $0.83 | -0.66 | $10.32 B | $10.54 B |
| 08/06/2020 | Q2 2020 | $1.46 | -$0.04 | -1.5 | $9.99 B | $10.13 B |
| 05/07/2020 | Q1 2020 | $1.48 | -$0.34 | -1.82 | $10.78 B | |
| 02/24/2020 | Q4 2019 | -$0.55 | $7.12 B | $7.95 B | ||
| 10/31/2019 | Q3 2019 | $1.06 | $0.83 | -0.23 | $5.90 B | $6.01 B |
Bristol-Myers Squibb Company Earnings: Frequently Asked Questions
-
When is Bristol-Myers Squibb Company's earnings date?
Bristol-Myers Squibb Company has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 31st, 2024 based off last year's report dates.
-
Did Bristol-Myers Squibb Company beat their earnings estimates last quarter?
In the previous quarter, Bristol-Myers Squibb Company (:BMY) reported $2.07 earnings per share (EPS) to beat the analysts' consensus estimate of $1.62 by $0.45.
-
How can I listen to Bristol-Myers Squibb Company's earnings conference call?
The conference call for Bristol-Myers Squibb Company's latest earnings report can be listened to online.
-
How can I read Bristol-Myers Squibb Company's conference call transcript?
The conference call transcript for Bristol-Myers Squibb Company's latest earnings report can be read online.
-
How much revenue does Bristol-Myers Squibb Company generate each year?
Bristol-Myers Squibb Company (:BMY) has a recorded annual revenue of $45.01 B.
-
How much profit does Bristol-Myers Squibb Company generate each year?
Bristol-Myers Squibb Company (:BMY) has a recorded net income of $45.01 B. Bristol-Myers Squibb Company has generated $3.88 earnings per share over the last four quarters.
-
What is Bristol-Myers Squibb Company's price-to-earnings ratio?
Bristol-Myers Squibb Company (:BMY) has a price-to-earnings ratio of -16.26 and price/earnings-to-growth ratio is -0.53.
